BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

HealthpointCapital to Acquire Ideal Medical Products


11/26/2007 7:06:51 AM

PARIS, Nov. 21 /PRNewswire/ -- HealthpointCapital Partners II, L.P., a private equity fund that specializes in orthopedic medical devices, announced today that, through its Healthpoint (Luxco) II S.a.r.l. subsidiary, it has acquired Paris-based Ideal Medical Products, S.A. Ideal Medical Products is the principal shareholder and will remain principal shareholder of leading spinal implant developer Scient'x, S.A.

John McCormick, a Managing Director of HealthpointCapital, said, "We are pleased to announce this all-cash acquisition of Ideal Medical Products. This will allow our firm to directly invest in and grow Scient'x by maintaining and leveraging our existing distributor relationships, investing in product innovation, surgeon training and clinical data programs globally and conducting FDA clinical trials in the United States. We look forward to growing Scient'x with its talented management team and employees."

Formed in 1989, Scient'x is recognized worldwide as a spinal product innovator, having invented key devices used every day in modern spinal fusion and other surgeries. Today, Scient'x sells over 25 distinct products for spinal fusion, motion preservation and total disc replacement.

Olivier Carli, President of Ideal Medical Products said, "I am very pleased with this transaction, which will allow all minority shareholders of Ideal Medical Products to achieve a significant cash premium for their holdings. I look forward to continuing to grow Scient'x with HealthpointCapital as our investment partner."

The acquisition is a two-step process. The initial euro 42.3 million cash payment will purchase the privately held Carli family interest in Ideal Medical Products, and then a tender offer will be made for the public minority interest of Ideal Medical Products for euro 21.56 cash per share. In addition, HealthpointCapital will assume certain assets and liabilities of Ideal Medical Products. Separately, Olivier Carli, Chairman and Chief Executive Officer, will acquire the majority of the Ideal Medical Products hospital engineering assets for euro 7.0 million.

About HealthpointCapital

HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the musculoskeletal sector -- specifically orthopedics and dental.

Our cumulative 85 years of experience in healthcare technology, research and private investing helps our clients capitalize on the growth and unique investment opportunities in one of the fastest growing sectors of the medical device industry.

HealthpointCapital manages $650 million of institutional capital.

Forward Looking Statements

This press release may contain forward-looking statements that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward- looking statements.

johnmccormick@healthpointcapital.com

CONTACT: John McCormick, Managing Director, HealthpointCapital, LLC,
+1-212-935-7780, johnmccormick@healthpointcapital.com

Web site: http://www.healthpointcapital.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES